Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Obesity but not overweight increases the incidence and mortality of leukemia in adults: A meta-analysis of prospective cohort studies.
Castillo JJ, Reagan JL, Ingham RR, Furman M, Dalia S, Merhi B, Nemr S, Zarrabi A, Mitri J.
Leuk Res. 2012 Jul;36(7):868-75. Epub 2012 Jan 29.
Related citations
The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line.
Xing H, Yang X, Liu T, Lin J, Chen X, Gong Y.
Leuk Res. 2012 Apr;36(4):509-13. Epub 2012 Jan 29.
Cytarabine in relapsed acute myeloid leukemia.
Hardesty BM, Cripe LD.
Leuk Res. 2012 Apr;36(4):387-8. Epub 2012 Jan 28. No abstract available.
Differential diagnosis of paediatric bone pain: acute lymphoblastic leukemia.
van der Have N, Nath SV, Story C, Tapp H, Nicola C, Moore S, Sutton R, Revesz T.
Leuk Res. 2012 Apr;36(4):521-3. Epub 2012 Jan 28. No abstract available.
Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC).
Jarosova M, Nedomova R, Hubacek J, Holzerova M, Mickova P, Katrincsakova B, Pikalova Z, Papajik T, Indrak K.
Leuk Res. 2012 Apr;36(4):e68-70. Epub 2012 Jan 28. No abstract available.
A comprehensive cytogenetic classification of 1466 Chinese patients with de novo acute lymphoblastic leukemia.
Li X, Li J, Hu Y, Xie W, Du W, Liu W, Li X, Chen X, Li H, Wang J, Zhang L, Huang S.
Leuk Res. 2012 Jun;36(6):720-6. Epub 2012 Jan 20.
A rare cryptic and complex rearrangement leading to MLL-MLLT10 gene fusion masked by del(10)(p12) in a child with acute monoblastic leukemia (AML-M5).
de Figueiredo AF, Vieira TP, Liehr T, Bhatt S, de Souza MT, Binato R, Marques-Salles Tde J, Carboni E, Ribeiro RC, Silva ML, Abdelhay E.
Leuk Res. 2012 Apr;36(4):e74-7. Epub 2012 Jan 18. No abstract available.
Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine.
Buchi F, Spinelli E, Masala E, Gozzini A, Sanna A, Bosi A, Ferrari G, Santini V.
Leuk Res. 2012 May;36(5):607-18. Epub 2012 Jan 9.
PDS5A, a novel translocation partner of MLL in acute myeloid leukemia.
Put N, Van Roosbroeck K, Vande Broek I, Michaux L, Vandenberghe P.
Leuk Res. 2012 Apr;36(4):e87-9. Epub 2012 Jan 9. No abstract available.
A novel recurrent translocation t(7;17)(q22;p13) and a late-appearing t(2;3)(p13;q26.2) with dysmegakaryopoiesis in acute myeloid leukemia.
Yamamoto K, Okamura A, Inui Y, Yakushijin K, Matsuoka H, Minami H.
Leuk Res. 2012 Apr;36(4):e84-6. Epub 2012 Jan 9. No abstract available.
N-terminally truncated WT1 variant (sWT1) is expressed at very low levels in acute myeloid leukemia and advanced phases of chronic myeloid leukemia.
Lopotová T, Nádvorníková S, Záčková M, Polák J, Schwarz J, Klamová H, Moravcová J.
Leuk Res. 2012 Apr;36(4):e81-3. Epub 2012 Jan 9. No abstract available.
RT-PCR diagnosis of recurrent rearrangements in pediatric acute lymphoblastic leukemia in Argentina.
Alonso CN, Gallego MS, Rossi JG, Medina A, Rubio PL, Bernasconi AR, Zubizarreta PA, Felice MS.
Leuk Res. 2012 Jun;36(6):704-8. Epub 2012 Jan 5.
Elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia.
Giles F, Rizzieri D, Ravandi F, Swords R, Jacobsen TF, O'Brien S.
Leuk Res. 2012 Apr;36(4):e71-3. Epub 2012 Jan 9. No abstract available.
Versatility and nuances of the architecture of haematopoiesis - Implications for the nature of leukaemia.
Brown G, Hughes PJ, Ceredig R, Michell RH.
Leuk Res. 2012 Jan;36(1):14-22. Epub 2011 Nov 8. Review.
Novel head-to-head gene fusion of MLL with ZC3H13 in a JAK2 V617F-positive patient with essential thrombocythemia without blast cells.
Duhoux FP, Ameye G, Lambert C, Herman M, Iossifidis S, Constantinescu SN, Libouton JM, Demoulin JB, Poirel HA.
Leuk Res. 2012 Jan;36(1):e27-30. Epub 2011 Oct 1. No abstract available.
In the absence of clinically significant graft vs. host disease, myeloablative conditioning may allow an effective graft vs. leukaemia effect.
Novitzky N, Thomas V.
Leuk Res. 2012 Jan;36(1):104-9. Epub 2011 Sep 19.
A rare case of childhood precursor B-cell lymphoblastic lymphoma in the mandible.
Sai S, Watanabe C, Okada S.
Leuk Res. 2012 Jan;36(1):e37-8. Epub 2011 Sep 6. No abstract available.
Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia.
Orlandi EM, Rocca B, Pazzano AS, Ghio S.
Leuk Res. 2012 Jan;36(1):e4-6. Epub 2011 Sep 3. No abstract available.
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.
Rauh MJ, Rahman F, Good D, Silverman J, Brennan MK, Dimov N, Liesveld J, Ryan DH, Burack WR, Bennett JM.
Leuk Res. 2012 Jan;36(1):81-6. Epub 2011 Sep 3. Review.
Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature.
Mathew RA, Bennett JM, Liu JJ, Komrokji RS, Lancet JE, Naghashpour M, Messina JL, List AF, Moscinski LC, Zhang L.
Leuk Res. 2012 Jan;36(1):72-80. Epub 2011 Jul 22. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on